showed a trendp = 0.08
However, MGMT-methylated glioblastomas showed a trend toward higher p90 values within the T1-CE ROI (3.76%) compared with MGMT-unmethylated tumors (3.46%; p = 0.08; see Table 2.2 ).
However, MGMT-methylated glioblastomas showed a trend toward higher p90 values within the T1-CE ROI (3.76%) compared with MGMT-unmethylated tumors (3.46%; p = 0.08; see Table 2.2 ).